Ilika plc Half year report reflects increased corporate interest

Ilika plc

Ilika Plc (LON:IKA), a pioneer in solid-state battery technology and materials innovation, announced today its unaudited half yearly report for the six months ended 31 October 2017.

Operational Highlights

· Exchanged detailed Stereax® performance data with over 60 potential OEM partners

· Shipped sample batteries to 10 potential OEM partners for detailed technical evaluation

· Three of these have progressed to development and deployment partnerships:

o Advanced a development programme to integrate a Stereax® battery in a miniature medical implant product (value to Ilika of £700,000 over 18 months from March 2017)

o Commenced a development programme to integrate a Stereax® battery with a photovoltaic energy harvesting solution from Lightricity (ex-Sharp) (value to Ilika of £320,000 over two years from July 2017)

o Secured a deployment programme with Titan Wind Energy, China’s largest wind turbine manufacturer, to use Stereax® M250 batteries to power strain sensors for turbine blade condition monitoring (value to Ilika of £400,000 over two years from March 2018)

· Continued to implement the Stereax® roadmap to achieve increased capacity per footprint and miniaturisation requirements

· Executed the following materials development programmes:

o plasmonic lenses and Heat Assisted Magnetic Recording (HAMR) materials with Seagate

o battery materials with Johnson Matthey

o game changing energy materials with Toyota and

o aerospace alloys in collaboration with partners including Rolls Royce, GKN and BAE Systems.

· Expanded proprietary IP with patents granted in USA for core-shell catalysts for fuel cells

· ISO 9001Certification achieved in December 2017

Financial Summary

· Total revenue for the period £1.0m (H1 2016: £0.3m)

· Loss per share 2p (H1 2016: 3p per share)

· Cash balance at period end £3.9m (H1 2016: £7.1m)

Commenting on the results Graeme Purdy, CEO of Ilika Plc, said: “In the first half of the year Ilika has delivered a series of Stereax® development and deployment partnerships which are driving revenue growth and enhancing insight into the addressable sectors for its technology. The progress being made towards the commercialisation of Stereax technology is illustrated by the increased number of Stereax® samples sent to a diverse range of potential OEM partners for evaluation. Ilika is well-positioned to generate value from its globally-recognised reputation for expertise in solid-state materials and battery technology and is seeing increased corporate interest consistent with greater activity in the global battery sector.”

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Ilika reports first Stereax revenues and Goliath progress

Ilika expects FY26 revenue of approximately £1.1m, including first commercial Stereax electrode sales, with Goliath evaluation activity expanding across automotive, defence and e-bike applications.

Defence battery demand highlights strategic opening for Ilika

Ilika highlights how rising defence and energy security demands are expanding the commercial opportunity for advanced battery technologies across military and infrastructure markets.

Ilika to showcase Stereax batteries to medical device manufacturers

Ilika’s Stereax batteries will be represented at Medical Technology Ireland 2026, giving the company direct exposure to medical device manufacturers and suppliers.

Ilika puts Stereax in front of medical device buyers

Ilika’s Stereax batteries will be represented at MEDevice Silicon Valley, putting the technology in front of medical device buyers and engineers.

Ilika to present solid-state battery progress at major UK energy storage conference

Ilika will present its Goliath quasi-solid-state cell technology at the Faraday Institution Conference 2026, giving investors a clear positioning update.

Search